Skip to main content
AGIO logo
AGIO
(NASDAQ)
Agios Pharmaceuticals, Inc.
$34.63-- (--)
Loading... - Market loading

Agios Pharmaceuticals (AGIO) Stock Price & Financial Analysis

Agios Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.14 - $35.38
52-Week High$46.00
52-Week Low$22.24
Open$33.14
Volume1.02M
Average Volume (3M)1.05M
Market Cap2.06B
Shares Outstanding59.49M
Price to Sales (P/S)20.95
Price to Book (P/B)2.01
EV/EBITDA-4.67
Revenue (TTM)98.34M
Net Income (TTM)-411.29M
Free Cash Flow (TTM)-365.25M
EPS (TTM)$-7.01
Profit Margin-418.24%
Operating Margin-466.78%
Return on Equity (ROE)-40.09%
Debt to Equity0.03
50-Day MA$35.49
200-Day MA$30.50
52-Week Change-4.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Agios Pharmaceuticals

What is the current stock price for AGIO?

As of the latest trading session, AGIO stock trades at $34.63. The 52-week range is $22.24–$46.00, with a day range of $33.14–$35.38.

What is the P/E ratio for AGIO?

The P/E ratio (Price-to-Earnings) for AGIO is shown in the Key Statistics section. This valuation metric helps compare Agios Pharmaceuticals, Inc. to industry peers.

Does AGIO pay dividends?

Agios Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for AGIO?

Based on 8 analysts, the consensus for AGIO is Buy.

What is the market cap of AGIO?

Agios Pharmaceuticals's market capitalization is $2.06B, classifying it as a mid-cap company. Agios Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.